Nov 03, 2022 / 08:00AM GMT
Operator
Welcome to the Novozymes conference call regarding the results for the first 9 months of 2022. (Operator Instructions) Today, I am pleased to announce Tobias Cornelius Bjorklund.
Tobias Cornelius Bjorklund - Novozymes A/S-Head of IR
So thank you, operator, and good morning, everyone, and welcome to our first 9 months results of 2022. My name is Tobias Bjorklund and I'm the Head of Investor Relations here at Novozymes. At this call, our CEO, Ester Baiget; and our CFO, Lars Green will review our performance and key events for the first 9 months of 2022 as well as the outlook for the year. Also attending today's call are Tina Fano, EVP, Agriculture and Industrial Biosolutions; Amy Byrick, EVP, Strategy and Business Transformation; Anders Lund, EVP, Consumer Biosolutions; and Claus Fuglsang, CSO and EVP of Research & Development. The entire call will take about 45 minutes, including time for questions at the end.
As always, I would like to remind you that the information presented during the call is unaudited and that
Q3 2022 Novozymes A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot